From a non-invasive point of view, it is important to note that although these are unpublished data, Ahmed and his team claim that methylation of the Gal-3 promoter was detected in all urine samples from PCa patients, but not in urine samples from kidney and bladder cancer patients [67]. The gene discussed is LGALS3; the disease is urinary bladder cancer.